
Biomerica (BMRA) Earnings Dates & Reports
Biomerica (BMRA) Most Recent Earnings
Report DateAug 29, 2022
Period EndingQ4 2022
Est. EPS-$1.12
Actual EPS-$1.12
EarningsMeet
Biomerica (BMRA) Earnings
View the latest Biomerica (BMRA) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Biomerica (BMRA)
Order type
Buy in
Order amount
Est. shares
0 shares
Biomerica (BMRA) Earnings per Share (EPS) History
Signup for full accessBrowse free
Biomerica (BMRA) Latest Earnings
The value each BMRA share was expected to gain vs. the value each share gained.
Biomerica (BMRA) reported its most recent earnings on Aug 29, 2022 for Q4 2022, posting earnings per share (EPS) of -$1.12. This exceeded analysts' expectations of -$1.12 by 0.00%, marking a Meet.
For comparison, Biomerica reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on 08/27/2025, with analysts projecting an EPS of $0.
Biomerica (BMRA) Earnings History
Biomerica (BMRA) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Biomerica’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Apr 14, 2025 | — | — | — |
Jan 14, 2025 | — | — | — |
Oct 15, 2024 | — | — | — |
Aug 28, 2024 | — | — | — |
Biomerica (BMRA) Earnings FAQs
Biomerica (BMRA) last reported earnings on Aug 29, 2022 for Q4 2022, posting an EPS of -$1.12, which Meet the estimate of -$1.12 by 0.00%.
For Q4 2022, Biomerica (BMRA) reported an EPS of -$1.12, missing analysts' estimate of -$1.12 by 0.00%.
For Q4 2022, Biomerica (BMRA) Meet expectations with an actual EPS of -$1.12 vs. an estimated EPS of -$1.12.
Following the last earnings report on Aug 29, 2022, Biomerica (BMRA)'s stock price moved — from — to —.
The next Biomerica (BMRA) earnings call is scheduled for Aug. 27, 2025, where executives will discuss financial results and outlook.